Tormere Analytics
Overview
Stock Research
Portfolio Lab
Options Lab
Watchlist
Screener
Convergence
Data Explorer
Learn
Newsletter
Pricing
Developer
Loading portfolio…
Kinnevik AB (publ) | Tormere
← Big Money
Kinnevik AB (publ)
Est. AUM
$65.56B
13F long equity, this entity only
Positions
1
Period
Sep 2025 (Q3)
SEC EDGAR
View filings ↗
Current Holdings
What Changed
Pro
Sep 2025 (Q3)
All
1
Long Equity
1
#
Issuer
Class
Value
Shares
% Portfolio
Discretion
1
Recursion Pharmaceuticals, Inc.
CL A
$65.56B
13434171
100.00%
DFND
Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.
